CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5494-5500

  Ishida, Takashi ^a   Inagaki, Hiroshi ^a   Utsunomiya, Atae ^b   Takatsuka, Yoshifusa ^b   Komatsu, Hirokazu ^a   Iida, Shinsuke ^a   Takeuchi, Genji ^c   Eimoto, Tadaaki ^a   Nakamura, Shigeo ^d   Ueda, Ryuzo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b IMAMURA BUN IN HOSPITAL   (Japan)

^c Saiseikai General Hospital   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR3; MESSENGER RNA;

ADOLESCENT; ADULT; AGED; ANAPLASTIC LYMPHOMA KINASE NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA; ANAPLASTIC LYMPHOMA KINASE POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; CANCER CLASSIFICATION; CANCER THERAPY; DRUG TARGETING; EXTRANODAL NATURAL KILLER CELL LYMPHOMA; EXTRANODAL T CELL LYMPHOMA; FEMALE; FOXP3 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYCOSIS FUNGOIDES; MYCOSIS FUNGOIDES IN TRANSFORMATION; NATURAL KILLER CELL; NATURAL KILLER CELL LYMPHOMA; PERIPHERAL T CELL LYMPHOMA UNSPECIFIED; PRECURSOR T LYMPHOBLASTIC LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; WORLD HEALTH ORGANIZATION CLASSIFICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; LYMPH NODES; LYMPHOMA; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; RECEPTORS, CHEMOKINE;

EID: 4143049161     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-0371     Document Type: Article

References (35)

1. Zlonik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000;12:121-7.
2. Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenviornment-specific lymphocyte homing. Curr Opin Immunol 2000;12:336-41.
3. Bucher EC, Williams M, Youngman K, Rott L, Briskin M. Lymphocyte trafficking and regional immunity. Adv Immunol 1999;72:209-53.
4. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature (Lond) 2001;410:50-6.
5. Qin S, Rottmann JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Investig 1998;101:746-54.
6. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129-34.
7. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998;161:5111-5.
8. Zingoni A, Soto H, Hedrick JA, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161:547-51.
9. + T cells. J Leuk Biol 2000;68:568-74.
10. Andrew DP, Ruffing N, Kim CH, et al. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol 2001;166:103-11.
11. Ralfkiaer E, Muller-Hermelink HK, Jaffe ES. Peripheral T-cell lymphoma, unspecified. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 227-9.
12. Clinical evaluation of the international Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
13. Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol 1998;9:849-55.
14. Ascani S, Zinzani PL, Gherlinzoni F, et al. Peripheral T-cell lymphomas. Clinicopathologic study of 168 cases diagnosed to the R.E.A.L. Classification. Ann Oncol 1997;8:583-92.
15. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de I'Adulte (GELA). Blood 1998;92:76-82.
16. Jones D, O'Hara C, Kraus MD, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood 2000;96:685-90.
17. Tsuchiya T, Ohshima K, Karube K, et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 2004;103:236-41.
18. Ishida T, Utsunomiya A, Iida S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma (ATLL): its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003;9:3625-34.
19. Kikuchi M, Jaffe ES, Ralfkiaer E. Adult T-cell leukaemia/lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 200-3.
20. Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000;101:455-8.
21. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
22. Shevach EM. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;6:389-400.
23. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Break down of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-64.
24. Ishida T, Iida S, Akatsuka Y, et al. CCR4: chemokine receptor as a novel molecular target for immunotherapy in adult T-cell leukemia/lymphoma (ATLL). [Abstract 3348]. Blood 2003;11:102.
25. Niwa R, Shoji-Hosaka E, Sakurada M, et al. Defucosylated chimeric anti-CCR4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma. Cancer Res 2004;64:2127-33.
26. Ackerman AB. If small plaque (digitate) parapsoriasis is a cutaneous T-cell lymphoma, even an 'abortive' one, it must be mycosis fungoides! Arch Dermatol 1996;132:562-6.
27. Imai T, Nagira M, Takagi S, et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999;11:81-8.
28. Brunning RD, Borowitz M, Matutes E, et al. Precursor T lymphoblastic leukaemia/lymphoblastic lymphoma (precursor T-cell acute lymphoblastic leukaemia) In: Jaffe ES, Harris NL, SteinH, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 115-7.
29. Chan JKC, Jaffe ES, Ralfkiaer E. Extranodal NK/T cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 204-7.
30. Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science (Wash D C) 1994;263:1281-4.
31. Delsol G, Ralfkiaer E, Stein H, Wright D, Jaffe ES. Anaplastic large cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 230-5.
32. Ralfkiaer E, Jaffe ES. Mycosis fungoides and Sezary syndrome. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics tumors of haematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. p. 216-20.
33. Ohshima K, Suzumiya J, Sato K, et al. Nodal T-cell lymphoma in an HTLV-1-endemic area: proviral HTLV-1 DNA, histological classification and clinical evaluation. Br J Haematol 1998;101:703-11.
34. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science (Wash D C) 2003;299:1057-61.
35. Shinkawa T, Nakamura K, Yamane N, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003;278:3466-73.